URGN 股价走势图
URGN 股票价格预测
Urogen Pharma Ltd
$29.72
0.74%
$0.21
收盘价：Jun 12, 16:00:00 GMT-4
$29.56
-0.53%
$-0.16
盘后：Jun 12, 20:00:00 GMT-4
返回
Urogen Pharma Ltd (URGN) 股票价格预测
关键数据
前收盘价
$29.5
开盘价
$29.48
当日区间
$29.32 - $31.28
52周范围
$3.42 - $32.37
交易量
581.0K
平均成交量
837.7K
股息收益率
--
每股收益（TTM）
-2.75
市值
$1.4B
什么是 URGN？
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. The firm is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).
